SCHEMBL5176072

SCHEMBL5176072

ClC1[CH]C(Cl)C(Cl)C(Cl)C1Cl

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
GABRA1 P14867 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRG2 P18507 1/20 0.46
GABRR1 P24046 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA6 Q16445 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lindane SCHEMBL7263148 0.74 LMNA (0.83) LMNACYP3A4GABRA1GABRB1GABRG2
SCHEMBL433010 0.68
Lindane SCHEMBL25895 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL8110265 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Beta-Hexachlorocyclohexane SCHEMBL25896 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL140812 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL8575655 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL75689 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Lindane SCHEMBL10795898 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2
Alpha-Hexachlorocyclohexane SCHEMBL140813 0.67 LMNA (1.00) LMNACYP3A4GABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070255064-A1 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids BASF AKTIENGESELLSCHAFT (DE) 2007-11-01 US disclosed
CN-101006062-A Imidazolium-methyl sulfites for use as starting compounds for producing ionic liquids BASF AG (DE) 2007-07-25 CN disclosed
EP-1786780-A1 IMIDAZOLIUM-METHYL SULFITES FOR USE AS STARTING COMPOUNDS FOR PRODUCING IONIC LIQUIDS BASF AKTIENGESELLSCHAFT (DE) 2007-05-23 EP disclosed
WO-2006021303-A1 IMIDAZOLIUM-METHYL SULFITES FOR USE AS STARTING COMPOUNDS FOR PRODUCING IONIC LIQUIDS BASF AKTIENGESELLSCHAFT (DE) 2006-03-02 WO disclosed
EP-1212307-A1 UNSATURATED OXIME ETHERS AND THE USE THEREOF FOR CONTROL OF HARMFUL FUNGI AND VETERINARY PESTS BASF AKTIENGESELLSCHAFT (DE) 2002-06-12 EP disclosed
EP-1172362-A1 Azadioxacycloalkenes and their use as fungicides and animal pesticides BASF AKTIENGESELLSCHAFT (DE) 2002-01-16 EP disclosed
WO-2001019803-A1 UNSATURATED OXIME ETHERS AND THE USE THEREOF FOR CONTROL OF HARMFUL FUNGI AND VETERINARY PESTS BASF AKTIENGESELLSCHAFT (DE) 2001-03-22 WO disclosed
US-4801708-A FOR AGRICULTURAL USE CIBA-GEIGY CORPORATION (US) 1989-01-31 US disclosed
EP-0150677-B1 HERBICIDAL AND INSECTICIDAL TRIAZINONES CIBA-GEIGY AG (CH) 1989-01-18 EP disclosed
EP-0150677-A1 Herbicidal and insecticidal triazinones CIBA-GEIGY AG (CH) 1985-08-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070255064-A1 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids CBR3, SCO2, PRMT5 LMNA 1862/4885CYP3A4 1927/4885GABRA1 2164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.